Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Most Insiders Tend To Buy Stock At The Right Time And Here Is Some Proof

Page 1 of 2

The Dow Jones Industrial Average has closed in the green for six straight trading sessions and continues its recovery from the recent correction. Similarly, the Standard and Poor’s 500 Index has posted gains in eight out of the past nine trading sessions, which is yet another sign that most market participants are regaining their confidence in equities. This confidence comes despite the S&P 500 third quarter earnings being anticipated to decline by 5.1% quarter-over-quarter, which will surely put downward pressure on U.S stocks if the estimations do indeed prove to be accurate. However, the low-level estimates may also allow companies to more easily surpass analysts’ expectations, which could push stock prices to higher levels. Moving on to the primary purpose of this article, the Insider Monkey team identified three companies with a high volume of insider buying activity recently, which could suggest these insiders are anticipating just such a third quarter beat. The companies are HC2 Holdings Inc. (NYSEMKT:HCHC), Coffee Holding Co. Inc. (NASDAQ:JVA), and Spark Therapeutics Inc. (NASDAQ:ONCE). Therefore, the following article will attempt to find out what might have propelled these companies’ insiders to purchase shares, be it firm-specific developments or broader market prospects.

Insider Trading Back

Luis Louro /

Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned more than 102% over the ensuing three-plus years, outperforming the S&P 500 Index by 53 percentage points (read the details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

To start, let’s take a glance at the insider buying activity at HC2 Holdings Inc. (NYSEMKT:HCHC). Philip A. Falcone, who has been serving as the company’s Chairman, President, and Chief Executive Officer since May 2014, purchased 540,000 shares last Friday for $7.50 each. These shares were acquired through a private offering under which HGI Funding sold its entire stake of 4.68 million shares. After the acquisition, the executive currently owns slightly more than 1.42 million shares. The shares of the diversified holding company are 10% in the red year-to-date and it is not entirely clear where they are heading from here. Exactly two months ago, HC2 Holdings released its earnings report for the second quarter, posting net revenues of $281.0 million, which were up by $79.2 million year-over-year. The company’s operating income came in at $3.3 million, compared to $0.8 million reported a year ago. Having these financial figures in mind, the third quarter earnings report of HC2 is likely to shed some light on the future course of the company. Dov Gertzulin’s DG Capital Management reported an ownership stake of slightly more than 811,000 shares in HC2 Holdings Inc. (NYSEMKT:HCHC) via its 13F filing for the June quarter.

Follow Hc2 Holdings Inc. (NYSEMKT:HCHC)
Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!